Precision Medicine Advancements Propel Expansion o..

Yeni makale yazdı

çevirmek 17 günler önce

Precision Medicine Advancements Propel Expansion of the Hereditary Cancer Testing Market | #hereditary Cancer Testing Market

Precision Medicine Advancements Propel Expansion of the Hereditary Cancer Testing Market

The hereditary cancer testing market size was estimated to be US$ 5.05 billion in 2021 and US$ XX billion in 2023 and is expected to reach US$ 14.59 billion by 2031; it is estimated to record a CAGR of 11.3% in 2023–2031.

Precision Medicine Advancements Propel Expansion of the Hereditary Cancer Testing Market

Beğen

Yorum Yap

Paylaş

640